Clene Inc
NASDAQ:CLNN 4:00:00 PM EDT
Market Cap (Intraday) | 113.69M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $1.53 |
50-Day MA | $1.21 |
200-Day MA | $2.23 |
Clene Inc Stock, NASDAQ:CLNN
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
United States of America
Phone: +1.801.676.9695
Number of Employees: 102
Description
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.